Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Radboud start fase I/II-studie naar COVID-19-vaccin
mrt 2021 | Vaccinatie, Virale infecties